EFFECT OF REBOXETINE ON REDUCTION OF ANXIETY SYMPTOMS IN DEPRESSED CHILDREN AND ADOLESCENTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

TASHAKORI A.; ARABGOL F.; PANAGHI L.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Jundishapur Scientific Medical Journal Year:2007 | Volume:6 | Issue:2 (53) Page(s): 210-218

Download Full-Text

Persian Verion

View:

1,276

Download:

Cites:

Information Journal Paper

Title

EFFECT OF REBOXETINE ON REDUCTION OF ANXIETY SYMPTOMS IN DEPRESSED CHILDREN AND ADOLESCENTS

Author(s)

TASHAKORI A. | ARABGOL F. | PANAGHI L. | Issue Writer Certificate

Keywords

ANXIETY SYMPTOMSQ3

DEPRESSIONQ2

CHILDRENQ2

ADOLESCENTSQ3

REBOXETINEQ3

Abstract

Objective: Anxiety is common in depressed CHILDREN and ADOLESCENTS. REBOXETINE is only norepinephrine reuptake inhibitor that may be useful for depressed adults with co-morbid anxiety. Thus this study is carried out to assess effect of REBOXETINE on ANXIETY SYMPTOMS of depressed CHILDREN and ADOLESCENTS.Subjects and Methods: This open trial is performed in twenty, outpatients with major depressive or dysthymic disorder with ANXIETY SYMPTOMS. Easy sampling was used. Dose of REBOXETINE was 4.36 ±1.20 mg/day. Hamilton Anxiety Rating Scale (HARS) was used to assess anxiety.Results: The 20 patients selected in studies (7-17 years old, mean 12.80 ± 2.82 years) (female=10, male=10). Following REBOXETINE administration, HARS score and its somatic and psychic factors were significantly reduced (p<0.001). In addition, ANXIETY SYMPTOMS were reduced about 43.22% during first week and 69.63% after 8 weeks of treatment.Conclusion: REBOXETINE does not exacerbate ANXIETY SYMPTOMS but quickly improves them during first week of administration. The effectiveness increases with prolonged use. Double blind -placebo controlled studies are needed to establish this conclusion.

Cites

رابطه شدت علائم مشکلات هیجانی و مسایل رفتاری با نحوه ترسیم آدمک در کودکان پیش دبستانی

References

No record.

Cite

APA: Copy

TASHAKORI, A., ARABGOL, F., & PANAGHI, L.. (2007). EFFECT OF REBOXETINE ON REDUCTION OF ANXIETY SYMPTOMS IN DEPRESSED CHILDREN AND ADOLESCENTS. JUNDISHAPUR SCIENTIFIC MEDICAL JOURNAL, 6(2 (53)), 210-218. SID. https://sid.ir/paper/12799/en

Vancouver: Copy

TASHAKORI A., ARABGOL F., PANAGHI L.. EFFECT OF REBOXETINE ON REDUCTION OF ANXIETY SYMPTOMS IN DEPRESSED CHILDREN AND ADOLESCENTS. JUNDISHAPUR SCIENTIFIC MEDICAL JOURNAL[Internet]. 2007;6(2 (53)):210-218. Available from: https://sid.ir/paper/12799/en

IEEE: Copy

A. TASHAKORI, F. ARABGOL, and L. PANAGHI, “EFFECT OF REBOXETINE ON REDUCTION OF ANXIETY SYMPTOMS IN DEPRESSED CHILDREN AND ADOLESCENTS,” JUNDISHAPUR SCIENTIFIC MEDICAL JOURNAL, vol. 6, no. 2 (53), pp. 210–218, 2007, [Online]. Available: https://sid.ir/paper/12799/en

Related Journal Papers